An electronic MEDLINE/PubMed search up to 24th January 2018 was performed, using the search terms (prostate cancer OR prostate adenocarcinoma) AND (MRI OR magnetic resonance) AND (biopsy naive OR active surveillance OR prior negative biopsy OR no prior biopsy). Only those studies which reported ...
[4]Stabile A, Giganti F, Rosenkrantz AB, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions[J]. Nat Rev Urol, 2020, 17(1): 41-61. DOI: 10.1038/ s41585-019-0212-4...
Prostate cancermpMRIPurpose Diagnosis of prostate cancer (CaP) is based on digital rectal examination (DRE) and/or elevated prostate specific antigen (PSA) level. This approach lacks sensitivity and specificity and is associated with many negative biopsies, high rate of diagnosing clinically ...
In this preliminary report from an ongoing clinical trial, 60 745 men aged 50 through 63 years were randomized either to be invited to undergo prostate cancer screening with a PSA test, a 4-kallikrein panel for those ...
EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71:618–29. Article Google Scholar Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol. 1989...
"My colleagues and I are thrilled about these results that show, without a doubt, that imaging and targeted biopsies are the future of prostate cancer diagnosis. We can catch more of the cancers we should be treating, avoid unnecessary treatment at the same time and improve the quality of li...
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and consequent overtreatment as well as underdiagnosis and missed diagnoses in many men. Multiparametric MRI (mpMRI) of the prostate has been identified as a test that
Professor, said, "The thought that over half the men with clinically significant cancer had a PSA less than 3 ng/ml and would have been reassured that they didn't have cancer by a PSA test alone is a sobering one and reiterates the need to consider a new approach to prostate cancer ...
The presentations cover a well-balanced, broad scope from practical, updated tips for optimized prostate MR acquisition and interpretation to new techniques such as PET MRI. PSMA PET imaging. Their role in the management of prostate cancer will be reviewed in addition to other hot topics in ...
[3]Fernández Guzman E.et al.Optimization in screening and diagnosis of Prostate Cancer (PCa): Use of Prostate Health Index (PHI) and mMRI in biopsy-naive patients(2020 EAU Abstract 45). [4]National Comprehensive Cancer Network. (NCCN) Clinical Practice Guidelines in Oncology. Prostate Cancer,...